On June 8, 2022 Shanghai Fosun Pharma reported that it will pay $158 million to acquire a 60% stake in a Singapore oncology medical center chain, Oncocare Medical Pte. Oncocare, with seven clinics in Singapore’s leading private medical centers, is one of Singapore’s largest private medical oncology specialist centers (Press release, Fosun Pharma, JUN 8, 2022, View Source [SID1234615848]). Most of the purchase, a 51% Oncocare share, was acquired from Aurora Healthcare, a company controlled by Dianbo Liu, the chairman of Hong Kong-listed Lue Pharma. About 10% of Fosun’s revenues derive from hospitals/clinics, and the company plans to expand its medical services coverage in China and Southeast Asia.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!